XCath Robotics’ Iris System Accepted into FDA’s Total Product Life Cycle Advisory Program (TAP) for Remote Robotic-Assisted Mechanical Thrombectomy in Acute Isc…

The U.S. Food and Drug Administration (FDA) has accepted XCath’s Iris Surgical Robotic System into its Total Product Life ...
Business Wire

BiVACOR Total Artificial Heart Accepted into FDA’s Total Product Life Cycle (TAP) Program

HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--BiVACOR, Inc., a clinical-stage medical device company developing the world’s first titanium Total Artificial Heart (TAH), today announced that its TAH ...